BioTech Firm Vicor Technologies Raises $2.7 Million

BOCA RATON - South Florida biotech firm Vicor Technologies has raised $2.72 million of its $2.95 million debt offering, according to a regulatory filing with the Securities and Exchange Commission.

The Boca Raton-based biotechnology company creates innovative, non-invasive diagnostics based on its patented PD2i nonlinear algorithm, a new vital sign that accurately predicts pathological events in specific populations.

It currently is in the process of commercializing diagnostics for such events as congestive heart failure patients for cardiac death resulting from arrhythmia or pump failure, diabetics for diabetic autonomic neuropathy, and trauma victims. Vicor is collaborating on one such project dealing with combat and civilian trauma victims with the U.S. Army Institute for Surgical Research at Fort Sam Houston in San Antonio, Texas.